Esperion Therapeutics Inc (NASDAQ:ESPR)
| 1.53 BATS BZX Real-Time Price As of 12:16pm ET |  -0.04 / -2.55%Today’s Change | 0.70 Today|||52-Week Range 7.41 | -75.44% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 236.0K | 252.0K | 258.0K | 265.0K | ||
| Operating Expenses | Gross Income | -236.0K | -252.0K | -258.0K | -265.0K | |
| General Expenses | 49.8M | 75.9M | 168.7M | 204.3M | ||
| Research And Development | 29.8M | 57.9M | 147.6M | 171.5M | ||
| Total Operating Expenses | 50.0M | 76.2M | 169.0M | 204.6M | ||
| Non-Operating Expenses | Operating Income | -50.0M | -76.2M | -169.0M | -204.6M | |
| Interest Expense On Debt | 520.0K | 376.0K | 198.0K | 100.0K | ||
| Other Expenses | -724.0K | -1.1M | -308.0K | 275.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -49.8M | -75.0M | -167.0M | -201.8M | |
| Net Income | -49.8M | -75.0M | -167.0M | -201.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 22.0M | 22.5M | 23.9M | 26.8M | |
| Shares To Calculate EPS Diluted | 22.0M | 22.5M | 23.9M | 26.8M | ||
| Earnings Per Share | EPS | -$2.26 | -$3.33 | -$6.98 | -$7.54 | |
| EPS Diluted | -$2.26 | -$3.33 | -$6.98 | -$7.54 | ||
